Landmark achievements of clinically approved nanomedicines in oncology. (IMAGE)
Caption
The figure encompasses key information, including trade names, active pharmaceutical ingredients (APIs), and nanoparticles (NPs) materials, regulatory agencies, such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), the Ministry of Food and Drug Safety (MFDS) of South Korea, and the National Medical Products Administration (NMPA) of China, as well as approval years and indications.
Credit
Chinese Medical Journal
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.
License
CC BY-NC-ND